A Multidisciplinary Approach To Inpatient Guideline Directed Medical Therapy And Transitions Of Care For Patients With Heart Failure Improves Readmission And Mortality

Sharon L. Huerta,Dmitry Yaranov,Amy Brewster

DOI: https://doi.org/10.1016/j.cardfail.2023.10.404

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Introduction The 2022 updated Guidelines for the Management of HF now emphasize the need for early and rapid initiation of GDMT. This prompted an initiative to increase provider knowledge of the new recommendations and overcome barriers to prescribing GDMT at a quaternary medical center. Hypothesis Increasing provider understanding of HF GDMT and removing financial barriers will increase the number of patients being discharged from the hospital on appropriate GDMT and reduce readmissions and mortality in patients with HF. Methods We have outlined a multidisciplinary approach to HF care at a large quaternary medical center with focus on readmission and mortality reduction (Figure 1). A major focus of our intervention was uptake of quadruple therapy (QT) and transitions of care between hospital and ambulatory settings. Provider education focused on current evidence-based practice recommendations for simultaneous initiation of QT at discharge, benefits and guidelines of SGLT2 inhibitors, and resources the pharmacy team has to overcome financial barriers for the costly drugs. The inpatient pharmacy team focused on patients with HFrEF for clinical review and GDMT optimization recommendations. Barriers to medication access were addressed by consulting the outpatient pharmacy team for formulary determinations, prior authorizations, and financial assistance options. GDMT prescribing was tracked by the GWTG-HF Registry. Readmission and mortality data was tracked using the Vizient Clinical Data Base. The HF program Clinical Nurse Specialist notified providers monthly of GDMT fallouts with education on the cause of the fallout, HF GDMT guidelines, and how to collaborate with pharmacy to overcome financial barriers. Results The percentage of patients discharged on appropriate QT increased from 9% in Jan 2022 to 100% in Jan 2023 in the GWTG sample. SGLT2-I prescribing for HFpEF similarly trended up. The all-payor readmission and mortality rates for the same time period trended down. Conclusion Increasing complexity of care for patients with HF demands a multidisciplinary approach to improve mortality and morbidity. Care transitions that include providers, nurse coordinators, and inpatient and outpatient pharmacists improve uptake of foundational therapies for HF and lead to improved outcomes. Socio-economic barriers and perceived lack of access to therapies in urban communities can be mitigated by a multidisciplinary approach to care.

cardiac & cardiovascular systems